An FP7 EU Funded R&D Project

The Science for Life Laboratory (SciLifeLab) from the KTH, Royal Institute of Technology, is devoted to high-throughput bioscience with a focus on biomedicine with a high relevance for MIRACLE in terms of technology, bioinformatics of biomarkers and biobanks. SciLifeLab is new initiative that will be formed jointly by the Royal Institute of Technology (KTH), the Karolinska Institute (KI) and Stockholm University (SU), and will physically bring together top researchers active in the field of molecular biosciences. The research groups at SciLifeLab will form an internationally outstanding research environment for high-throughput biosciences and translational medicine. Initially, five core platforms will be established (genome analysis, proteome profiling, high-throughput functional genomics, bioimaging and bioinformatics). SciLifeLab will provide a competitive basis for multi-disciplinary research requiring an integrated advanced technological infrastructure. SciLifeLab will establish in state-of-the-art methods for high-throughput generation of biological data and one of the largest infrastructures in Europe dedicated to bioinformatics and computational biology. Several medical research programs will be pursued, all aimed to take advantage of the synergies obtained by collaborative use of two or more of the infrastructure platforms. These programs include biobank profiling, cancer, infectious disease and metagenomics, human genetic disease, cellular profiling, developmental and epigenetic profiling, human membrane proteome profiling and systems biology.

The KTH will be involved in the optimization of molecular assays on-chip.
KTH Royal Institute of Technology, Stockholm, Sweden